Got the feeling the market doesn't care and will be waiting until bulk sampling confirm JR' targets are loaded with diamonds. Back in the bottom draw for a few months.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025